Wells Fargo Adjusts NovoCure's Price Target to $49 From $102, Keeps Overweight Rating
-- NovoCure has an average rating of outperform and price targets ranging from $23 to $49, according to analysts polled by Capital IQ. Price: 20.43, Change: +1.83, Percent Change: +9.81 ...